Cite
Zhang W, Hu B, Han J, et al. Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients. Front Oncol. 2021;11:747950doi: 10.3389/fonc.2021.747950.
Zhang, W., Hu, B., Han, J., Wang, Z., Ma, G., Ye, H., Yuan, J., Cao, J., Zhang, Z., Shi, J., Chen, M., Wang, X., Xu, Y., Cheng, Y., Tian, L., Wang, H., & Lu, S. (2021). Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients. Frontiers in oncology, 11747950. https://doi.org/10.3389/fonc.2021.747950
Zhang, Wenwen, et al. "Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients." Frontiers in oncology vol. 11 (2021): 747950. doi: https://doi.org/10.3389/fonc.2021.747950
Zhang W, Hu B, Han J, Wang Z, Ma G, Ye H, Yuan J, Cao J, Zhang Z, Shi J, Chen M, Wang X, Xu Y, Cheng Y, Tian L, Wang H, Lu S. Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients. Front Oncol. 2021 Oct 19;11:747950. doi: 10.3389/fonc.2021.747950. eCollection 2021. PMID: 34737958; PMCID: PMC8560793.
Copy
Download .nbib